Crocs Stock Soars 22%, Adding $1.3 Billion, As HEYDUDE Returns To Growth And Profit Outlook Rises

The footwear maker raised its 2026 adjusted earnings forecast for the third time this year, and its CFO expects growth in 2027.

Share
Crocs Stock Soars 22%, Adding $1.3 Billion, As HEYDUDE Returns To Growth And Profit Outlook Rises

Crocs shares climbed 21.95% to $145.96 in Thursday trading, as of 10:32 AM ET, adding $1.3 billion in market value, after the footwear maker raised its full-year profit forecast for the third time this year. HEYDUDE, its struggling loafer brand, grew again.

A higher bar for 2026 earnings

Crocs, which sells molded clogs, sandals and Jibbitz charms under the Crocs Brand and loafer-style shoes under HEYDUDE, lifted its 2026 outlook to $14.45–$14.65 in adjusted earnings per share.

Third-quarter revenue rose 4.6% to $1.04 billion, and adjusted earnings reached $3.69 a share, according to the company's results. HEYDUDE revenue grew 6% and Crocs Brand revenue rose 4%.

On the earnings call, the CFO said 2027 should be a growth year, at a pace roughly matching this year's.

Buybacks and a 40% run

Crocs spent $250 million on share repurchases in the third quarter, buying 2 million shares at an average price of $123.32, the company said.

The stock was on pace for its third straight daily gain and its biggest one-day gain since Sept. 25, 2025. Through Wednesday's close, it was up about 40% this year, against about 13% for the S&P 500, and had been recovering from a 52-week low of $73.21.

The business behind the numbers

Crocs sells through wholesale partners, which made up 47.9% of 2025 revenue, and directly to consumers, 52.1%. As of December 31, 2025, it ran 514 company stores and sold in more than 85 countries.

Its last quarterly report, for the period ended June 30, showed revenue of $1.2 billion, up 2.6% from a year earlier, with a 24.2% operating margin.

The third-quarter buyback averaged $123.32 a share; Thursday's price of $145.96 sits above it.

Sources

More on Crocs

All Crocs (CROX) coverage →